| Characteristic | GLIM(-) N = 1441 |
GLIM(+) N = 711 |
p-value2 |
|---|---|---|---|
| Sex(male) | 84 (58%) | 40 (56%) | 0.8 |
| Age | 61.5 [51.5–72.5] | 71.0 [56.0–78.0] | 0.007 |
| BMI | 23.7 [21.4–25.9] | 19.5 [17.4–22.6] | <0.001 |
| SOFA | 2.0 [1.0–5.0] | 5.0 [2.0–8.0] | <0.001 |
| AKI stage | 0.006 | ||
| 0 | 105 (73%) | 36 (51%) | |
| 1 | 21 (15%) | 14 (20%) | |
| 2 | 7 (4.9%) | 7 (9.9%) | |
| 3 | 11 (7.6%) | 14 (20%) | |
| CKD stage | 0.002 | ||
| 1 | 64 (44%) | 18 (25%) | |
| 2 | 45 (31%) | 20 (28%) | |
| 3 | 29 (20%) | 20 (28%) | |
| 4 | 4 (2.8%) | 7 (9.9%) | |
| 5 | 2 (1.4%) | 6 (8.5%) | |
| HD | 2 (1.4%) | 8 (11%) | 0.003 |
| Heart Failure | 18 (13%) | 13 (18%) | 0.3 |
| Stroke | 17 (12%) | 8 (11%) | >0.9 |
| Cardiopulmonary Arrest | 2 (1.4%) | 2 (2.8%) | 0.6 |
| Post surgery | 120 (83%) | 46 (65%) | 0.002 |
| Respiratory Failure | 7 (4.9%) | 7 (9.9%) | 0.2 |
| Metabolic Disorder | 53 (37%) | 30 (42%) | 0.4 |
| ICU LOS | 2.0 [2.0–3.5] | 3.0 [2.0–6.0] | 0.005 |
| LOS | 17.0 [12.0–36.5] | 26.0 [17.0–42.0] | 0.011 |
| ³連続変数は中央値 [四分位範囲]、カテゴリ変数は数（割合）で表示。p値はWilcoxon順位和検定またはχ²検定で算出。 | |||
| 1 n (%); Median [Q1–Q3] | |||
| 2 Pearson’s Chi-squared test; Wilcoxon rank sum test; Fisher’s exact test | |||